journal cover

In Vitro Activity of a Novel Glucan Synthase Inhibitor, SCY-078, against Clinical Isolates of Candida auris

Antimicrobial Agents and Chemotherapy

May 10, 2017

Elizabeth L BerkowShawn R Lockhart

Abstract

No abstract listed.

Mentioned in this Paper

Pathogenic Organism
Antibiotics, Antifungal
Inhibitors
Candida (fungus)
Candidiasis
Isolate - Microorganism
Fungi
Antibiotic Resistance, Fungal
Glucan synthase
Triterpenes
1
18
22
Paper Details
References
  • References7
  • Citations20
1
  • References7
  • Citations20
12

Feeds With Similar Papers

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Vitamin K Carboxylase & Antibiotics

Vitamin K-dependent carboxylases generate gamma-carboxyglutamic acids with malonate moieties by modifying glutamate residues in vitamin K-dependent proteins. This feed focuses on cellular mechanisms regulated by vitamin K-dependent carboxylases.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Related Papers

The Journal of Antimicrobial Chemotherapy

The novel oral glucan synthase inhibitor SCY-078 shows in vitro activity against sessile and planktonic Candida spp

The Journal of Antimicrobial ChemotherapyFebruary 9, 2017
Laura Judith Marcos-ZambranoJesús Guinea
Medical Mycology

Isolates of the emerging pathogen Candida auris present in the UK have several geographic origins

Medical MycologyFebruary 17, 2017
Andrew BormanElizabeth M Johnson
© 2020 Meta ULC. All rights reserved

In Vitro Activity of a Novel Glucan Synthase Inhibitor, SCY-078, against Clinical Isolates of Candida auris

Antimicrobial Agents and Chemotherapy

May 10, 2017

Elizabeth L BerkowShawn R Lockhart

PMID: 28483955

DOI: 10.1128/aac.00435-17

Abstract

No abstract listed.

Mentioned in this Paper

Pathogenic Organism
Antibiotics, Antifungal
Inhibitors
Candida (fungus)
Candidiasis
Isolate - Microorganism
Fungi
Antibiotic Resistance, Fungal
Glucan synthase
Triterpenes
1
18
22

Feeds With Similar Papers

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Related Papers

The Journal of Antimicrobial Chemotherapy

The novel oral glucan synthase inhibitor SCY-078 shows in vitro activity against sessile and planktonic Candida spp

The Journal of Antimicrobial ChemotherapyFebruary 9, 2017
Laura Judith Marcos-ZambranoJesús Guinea
Medical Mycology

Isolates of the emerging pathogen Candida auris present in the UK have several geographic origins

Medical MycologyFebruary 17, 2017
Andrew BormanElizabeth M Johnson
Paper Details
References
  • References7
  • Citations20
1
  • References7
  • Citations20
12

Download from

Publisher
PubMed
/papers/in-vitro-activity-of-a-novel-glucan-synthase/28483955